Val Curtis Global Handwashing Day is October 15th, 2008: an opportunity to remind everybody that millions of lives, especially children’s lives, can be saved by avoiding diarrhoea and other dise

Val Curtis
Global Handwashing Day is October 15th, 2008: an opportunity to remind everybody that millions of lives, especially children’s lives, can be saved by avoiding diarrhoea and other diseases spread when mothers, fathers, family members and friends fail to wash their hands with both soap and water. Derek Thorne hears fromVal CurtisandRobert Aungerat the London School who are spearheading initiatives all over the world to reduce this loss of life by persuading people to get into the habit of washing their hands after using the toilet.
Peter Goodwin learns fromKaye Wellingsof the School about the latest phase of her massive study of sexual attitudes, behaviour and health which for the first time is looking at over 60s, and also at positive, as well as negative sexual health outcomes. Also:Martin McKeetalks about the way TB has spread in the community at large as prison populations have increased in countries of the former Soviet Union. AndMichel Colemandiscusses with Peter Goodwin (during the NCRI Cancer Conference in Birmingham) his data showing that organisation and resources in cancer care are more significant determinants of survival than specific drugs used on patients.

Robert Aunger

Kaye Wellings

Martin McKee

Michel Coleman
Related Episodes

Hassan Mohammed Abushukair MD; AACR 2026: Immune Checkpoint Inhibitor-Induced Myocarditis within One Month Predicts Lethal “Triple M Overlap Syndrome”
Immune Checkpoint Inhibitor-Induced Myocarditis within One Month Predicts Lethal “Triple M Overlap Syndrome” An interview with: Hassan Mohammed Abushukair MD, Post-Doctoral Researcher, Oklahoma Univer

Aditya Bardia MD MPH; 2025 San Antonio Breast Cancer Symposium: Selective Estrogen Degrader Giredestrant Improves on Standard Endocrine Therapy for Patients with ER-positive, HER2-negative Early Breast Cancer: Phase III lidERA Breast Cancer trial Findings
A seective estrogen degrader out-performed AI’s in ER+ HER- early breast cancer

Li Zhang MD; ESMO 2025: Patients with EGFR-mutated Lung Cancer Progressing After Tyrosine Kinase Therapy Live Longer with Sacituzumab Tirumotecan Therapy
Antibody Drug Conjugate Prolongs Life in NSCLC refractory to EGFR TKI Therapy
